By Counterforce Health Team in Mavenclad (cladribine tablets) —

How to Get Mavenclad (Cladribine Tablets) Covered by Aetna CVS Health in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Mavenclad Covered by Aetna CVS Health in Georgia

Aetna CVS Health requires prior authorization for Mavenclad (cladribine tablets) with documented failure of at least 2 disease-modifying therapies, lymphocyte count ≥800 cells/μL, and neurologist prescription. Submit PA via Availity portal or fax to 1-866-249-6155. If denied, you have 180 days for internal appeal, then 60 days for external review through Georgia Department of Insurance.

First step today: Call CVS Caremark (number on your insurance card) to verify specialty tier coverage and deductible, then ask your neurologist to gather prior DMT records and recent labs for the PA submission.

Table of Contents

Coverage Requirements at a Glance

Requirement Details Where to Find It
Prior Authorization Mandatory for initial and renewal Aetna precertification list
Step Therapy Failure of ≥2 DMTs (interferon, glatiramer, fingolimod, etc.) Document names, dates, failure reasons
Lab Requirements Lymphocyte count ≥800 cells/μL within 3 months Recent CBC with differential
Prescriber Neurologist or MS specialist Referral if needed from PCP
Pharmacy CVS Specialty only Automatic transfer after approval
Diagnosis Code G35.A (RRMS) or G35.C1 (active SPMS) 2025 ICD-10 updates
Formulary Tier Specialty tier (20-40% coinsurance) Check member portal

Step-by-Step: Fastest Path to Approval

1. Verify Your Coverage

Who: You or clinic staff
Action: Call CVS Caremark (number on insurance card) to confirm:

  • Specialty tier status and coinsurance
  • Annual deductible remaining
  • CVS Specialty Pharmacy requirement Timeline: 10-15 minutes

2. Gather Required Documentation

Who: Your neurologist's office
Documents needed:

  • Prior DMT history with exact names, dates, doses
  • Failure reasons (relapses, new lesions, intolerance)
  • Recent labs (CBC, metabolic panel, liver function)
  • MRI showing disease activity
  • ICD-10 diagnosis confirmation (G35.A or G35.C1) Timeline: 1-2 weeks to collect

3. Submit Prior Authorization

Who: Neurologist
How: Availity provider portal or fax to 1-866-249-6155
Include: Medical necessity letter, all documentation from step 2
Timeline: 72 hours for standard review, 24 hours expedited

4. Track Your Request

Who: You or clinic
Action: Call 1-855-582-2025 with member ID to check status
Follow-up: Request peer-to-peer review if pending >5 days

5. If Approved: Coordinate Delivery

Who: CVS Specialty Pharmacy
Timeline: Contact within 24-48 hours for delivery scheduling
Action: Confirm copay assistance enrollment

Medical Coding That Supports Your Case

ICD-10 Codes for Multiple Sclerosis

The 2025 ICD-10 updates provide specific codes that insurers use to verify Mavenclad eligibility:

  • G35.A: Relapsing-remitting multiple sclerosis
  • G35.C1: Active secondary progressive MS (with ongoing relapses/inflammation)
  • G35.C0: Secondary progressive MS, unspecified
Clinician Corner: Ensure your medical records explicitly state the MS subtype and activity status. Generic "G35 Multiple sclerosis" coding may trigger additional review or denial. Document phrases like "active relapsing-remitting MS with recent gadolinium-enhancing lesions" support the specific codes insurers expect.

HCPCS and NDC Information

  • Primary HCPCS: J8499 (prescription drug, NOC) for oral tablets
  • Alternative: J9065 (injection, cladribine, per 1 mg) sometimes used
  • NDC: 44087-4000 (10 mg tablets, 10-tablet carton)
  • Billing Units: Per tablet (e.g., 4 tablets = 4 units for 40 mg)

Pharmacy vs. Medical Benefit

Mavenclad falls under specialty pharmacy benefit due to oral administration, not medical benefit. This means:

  • Processed through CVS Specialty Pharmacy
  • Subject to pharmacy deductible and coinsurance
  • Requires specialty tier prior authorization

Common Denial Reasons & How to Fix Them

Denial Reason Fix Strategy
Incomplete prior therapy documentation Submit detailed records with drug names, exact dates (≥3-6 months each), doses, and specific failure reasons (relapses, new MRI lesions, intolerance symptoms)
Step therapy not met Provide evidence of ≥2 DMT failures; request peer-to-peer review with neurologist to discuss clinical rationale
Low lymphocyte count Retest when ≥800 cells/μL; submit trending labs showing recovery from previous treatments
"Not medically necessary" Appeal with MS treatment guidelines, FDA labeling, and specialist letter explaining why alternatives are inappropriate
Non-formulary status Request formulary exception with documentation that preferred alternatives have failed or are contraindicated

Appeals Process in Georgia

Internal Appeal with Aetna CVS Health

  • Deadline: 180 days from denial notice
  • How to file: Call member services or submit via member portal
  • Required documents: Denial letter, medical records, prescriber letter
  • Timeline: Decision within 30 days (expedited within 72 hours if urgent)

External Review through Georgia DOI

If your internal appeal is denied, Georgia law provides a second chance through independent review:

  • Deadline: 60 days from final internal denial
  • How to file: Call 1-800-656-2298 or submit online at oci.georgia.gov
  • Cost: Free to consumers
  • Timeline: 30 days standard, 72 hours for expedited reviews
  • Decision: Legally binding on Aetna if approved
Note: Georgia's external review applies to fully insured Aetna plans. If you have employer coverage, check with HR whether your plan is self-funded (ERISA), which may limit external review options.

Required Documents for External Review:

  • All Aetna denial letters
  • Complete medical records
  • Neurologist letter explaining medical necessity
  • Evidence of prior DMT failures
  • Recent MRI and lab results

Cost and Financial Assistance

Typical Costs

  • 2-year course: Often exceeds $100,000 before insurance
  • With Aetna coverage: 20-40% coinsurance on specialty tier
  • Deductible: Applies before coinsurance kicks in

Financial Assistance Options

  • Merck Patient Assistance Program: Income-based free drug program
  • Copay savings: Up to $15,000/year for commercially insured patients
  • National MS Society: Financial assistance grants at 1-800-344-4867
  • Patient Advocate Foundation: Copay relief program
Important: Medicare and Medicaid patients cannot use manufacturer copay cards but may qualify for foundation grants.

When to Escalate

Contact Georgia Department of Insurance Consumer Services if:

  • Aetna misses appeal deadlines
  • You need help filing external review
  • Aetna ignores step therapy exception requests
  • You suspect bad faith claim handling

Georgia DOI Contact:

Additional support resources:

  • Georgians for a Healthy Future: Consumer appeal guidance
  • Georgia Legal Services Program: Free legal help for eligible residents

FAQ

How long does Aetna CVS Health prior authorization take in Georgia? Standard PA decisions take 72 hours. Expedited reviews (for urgent medical situations) are completed within 24 hours. You can track status by calling 1-855-582-2025.

What if Mavenclad isn't on my Aetna formulary? Request a formulary exception by having your neurologist submit documentation that preferred alternatives have failed or are medically inappropriate. Many non-formulary denials are reversed on appeal.

Can I get an expedited appeal if my MS is worsening? Yes. If delay in treatment could seriously jeopardize your health, request expedited internal appeal (72-hour decision) and expedited external review if needed. Your doctor must certify the urgency.

Does step therapy apply if I tried DMTs in another state? Yes, prior therapy history from any location counts toward step therapy requirements. Ensure your new Georgia neurologist has complete records from previous providers.

What happens if I can't afford the copay after approval? Enroll in Merck's copay assistance program (up to $15,000/year) and apply for grants from the National MS Society or Patient Advocate Foundation. CVS Specialty can help coordinate these programs.

How do I know if my employer plan qualifies for Georgia external review? Fully insured plans qualify for state external review. Self-funded ERISA plans may not, but Aetna offers voluntary external review for some. Check your plan documents or call HR to confirm your plan type.

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and payer policies to draft point-by-point rebuttals that align with each plan's specific requirements, improving approval rates for complex medications like Mavenclad.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and state regulations may change. Always verify current requirements with your insurer and healthcare providers. For personalized assistance with appeals, consult qualified professionals or organizations like Counterforce Health.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.